These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25797748)

  • 1. Discussion.
    J Am Coll Surg; 2015 Apr; 220(4):625-7. PubMed ID: 25797748
    [No Abstract]   [Full Text] [Related]  

  • 2. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
    Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
    Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
    [No Abstract]   [Full Text] [Related]  

  • 3. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
    Rosario PW
    Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?
    Kiernan CM; Parikh AA; Parks LL; Solórzano CC
    J Am Coll Surg; 2015 Apr; 220(4):617-25. PubMed ID: 25667136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
    Marti JL; Davies L; Haymart MR; Roman BR; Tuttle RM; Morris LG
    Thyroid; 2015 Jul; 25(7):865-6. PubMed ID: 25963001
    [No Abstract]   [Full Text] [Related]  

  • 6. Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
    Zhao J; Dong J; Sun Q; Wang H; Zhang Z; Zhou X; Liao L
    Chin Med J (Engl); 2014; 127(16):3039-40. PubMed ID: 25131255
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer.
    Nixon IJ; Ganly I
    Future Oncol; 2013 Jul; 9(7):921-3. PubMed ID: 23837752
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VISUAL VIGNETTE.
    Narwani V; Kempf J; Lubitz S
    Endocr Pract; 2017 May; 23(5):633. PubMed ID: 27631845
    [No Abstract]   [Full Text] [Related]  

  • 11. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.
    Patel SS; Goldfarb M
    J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postradial sialozoadenitis in patients with papillary carcinoma of the thyroid gland].
    Kovalenko VA; Kopchak AV; Kovalenko AE
    Vestn Khir Im I I Grek; 2015; 174(1):75-7. PubMed ID: 25962302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual vignette.
    Saberi S; Esfandiari NH
    Endocr Pract; 2015 May; 21(5):558. PubMed ID: 25297672
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of papillary carcinoma of the thyroid occurring after irradiation.
    Crile G
    Surg Gynecol Obstet; 1980 Jun; 150(6):850-2. PubMed ID: 7376046
    [No Abstract]   [Full Text] [Related]  

  • 15. Remarkable response to radioiodine therapy in a case of metastatic macrofollicular variant of papillary thyroid carcinoma.
    Marques P; Leite V; Bugalho MJ
    Clin Nucl Med; 2014 Feb; 39(2):219-21. PubMed ID: 24368535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.
    Goffredo P; Thomas SM; Dinan MA; Perkins JM; Roman SA; Sosa JA
    JAMA Intern Med; 2015 Apr; 175(4):638-40. PubMed ID: 25686394
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Prates BS; Silva LC; Calsolari MR
    Thyroid; 2012 Nov; 22(11):1140-3. PubMed ID: 23050786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Management of cancer of the thyroid: a summary.
    Strong EW
    Proc Natl Cancer Conf; 1972; 7():179-85. PubMed ID: 4587645
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachronous solitary metastasis of papillary thyroid cancer in the cavernous sinus: case report and review of literature.
    Chandarana MN; Epari S; Chaukar D; Moiyadi AV
    J Cancer Res Ther; 2012; 8(3):436-8. PubMed ID: 23174730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.